TY - JOUR T1 - Correction: <em>Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer</em> JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 1084 LP - 1084 DO - 10.1136/ijgc-2019-001012corr1 VL - 30 IS - 7 A2 - , Y1 - 2020/07/01 UR - http://ijgc.bmj.com/content/30/7/1084.abstract ER -